Biolidics Limited (SGX:8YY)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.0210
-0.0010 (-4.55%)
At close: Jun 5, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Laboratory Services
1.04M
Log In
Log In
Log In
Log In
Upgrade
Laboratory Services Growth
-46.46%
Log In
Log In
Log In
Log In
Upgrade
Cancer
278.00K
Log In
Log In
Log In
Log In
Upgrade
Cancer Growth
33.65%
Log In
Log In
Log In
Log In
Upgrade
Infectious Diseases
-
Log In
Log In
Log In
Log In
Upgrade
Infectious Diseases Growth
-
Log In
Log In
Log In
Log In
Upgrade
Global Commercial Channel Management
-
Log In
Log In
Log In
Log In
Upgrade
Global Commercial Channel Management Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Singapore
1.04M
Log In
Log In
Log In
Log In
Upgrade
Singapore Growth
-52.28%
Log In
Log In
Log In
Log In
Upgrade
Thailand
89.00K
Log In
Log In
Log In
Log In
Upgrade
Japan
66.00K
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
106.25%
Log In
Log In
Log In
Log In
Upgrade
Malaysia
64.00K
Log In
Log In
Log In
Log In
Upgrade
Hong Kong
38.00K
Log In
Log In
Log In
Log In
Upgrade
Hong Kong Growth
-51.28%
Log In
Log In
Log In
Log In
Upgrade
United States
14.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-
Log In
Log In
Log In
Log In
Upgrade
Europe
7.00K
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-65.00%
Log In
Log In
Log In
Log In
Upgrade
Philippines
2.00K
Log In
Log In
Log In
Log In
Upgrade
Philippines Growth
-85.71%
Log In
Log In
Log In
Log In
Upgrade
Taiwan
-
Log In
Log In
Log In
Log In
Upgrade
Indonesia
-
Log In
Log In
Log In
Log In
Upgrade
Indonesia Growth
-
Log In
Log In
Log In
Log In
Upgrade
China
-
Log In
Log In
Log In
Log In
Upgrade
China Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade